Bio Blast Pharma Ltd (ORPN) - Financial and Strategic SWOT Analysis Review

  • ID: 4284957
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

Bio Blast Pharma Ltd (Bioblast) is a clinical stage biotechnology company that discovers, develops, and delivers clinical therapies for patients with rare and ultra-rare genetic diseases. The company develops pipeline products using platforms such as cabaletta, a mutant protein stabilizing platform based on a small repurposed molecule; BBrm a read-through platform based on a small repurposed molecule; and mPRT, a mitochondrial protein replacement platform based on biological fusion proteins. Its drug candidate includes trehalose 90 mg/mL IV solution. The company operates in the US and Israel. Bioblast is headquartered in Tel-Aviv, Israel.

Bio Blast Pharma Ltd Key Recent Developments

Nov 02, 2017: Bioblast Pharma Reports Third Quarter 2017 Financial Results
Aug 04, 2017: Bioblast Pharma Reports Second Quarter 2017 Financial Results
May 26, 2017: Bioblast Pharma Reports First Quarter 2017 Financial Results
Feb 24, 2017: Bioblast Pharma Reports Fourth Quarter and Year End 2016 Financial Results

This comprehensive SWOT profile of Bio Blast Pharma Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Bio Blast Pharma Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Bio Blast Pharma Ltd - Key Information
  • Bio Blast Pharma Ltd - Overview
  • Bio Blast Pharma Ltd - Key Employees
  • Bio Blast Pharma Ltd - Key Employee Biographies
  • Bio Blast Pharma Ltd - Key Operational Heads
  • Bio Blast Pharma Ltd - Major Products and Services
  • Bio Blast Pharma Ltd - History
  • Bio Blast Pharma Ltd - Company Statement
  • Bio Blast Pharma Ltd - Locations And Subsidiaries
  • Bio Blast Pharma Ltd - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Bio Blast Pharma Ltd - Business Description
  • Bio Blast Pharma Ltd - Corporate Strategy
  • Bio Blast Pharma Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Bio Blast Pharma Ltd - Strengths
  • Bio Blast Pharma Ltd - Weaknesses
  • Bio Blast Pharma Ltd - Opportunities
  • Bio Blast Pharma Ltd - Threats
  • Bio Blast Pharma Ltd - Key Competitors
Section 3 - Company Financial Performance Charts
  • Bio Blast Pharma Ltd - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Bio Blast Pharma Ltd, Key Information
  • Bio Blast Pharma Ltd, Key Ratios
  • Bio Blast Pharma Ltd, Share Data
  • Bio Blast Pharma Ltd, Major Products and Services
  • Bio Blast Pharma Ltd, History
  • Bio Blast Pharma Ltd, Key Employees
  • Bio Blast Pharma Ltd, Key Employee Biographies
  • Bio Blast Pharma Ltd, Key Operational Heads
  • Bio Blast Pharma Ltd, Other Locations
  • Bio Blast Pharma Ltd, Subsidiaries
  • Bio Blast Pharma Ltd, Key Manufacturing facilities
  • Bio Blast Pharma Ltd, Key Competitors
  • Bio Blast Pharma Ltd, SWOT Analysis
  • Bio Blast Pharma Ltd, Ratios based on current share price
  • Bio Blast Pharma Ltd, Annual Ratios
  • Bio Blast Pharma Ltd, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Bio Blast Pharma Ltd, Performance Chart
  • Bio Blast Pharma Ltd, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll